Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling

FEMS Microbiology Letters

Volumn 238, Issue 1, 2004, Pages 221-226

  Farnaud, Sebastien ^a   Patel, Alpesh ^a   Odell, Edward W ^b   Evans, Robert W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cationic antimicrobial peptides; Lactoferricin; Lactoferrin; LPS; Modeller

Indexed keywords

LACTOFERRICIN; LIPOPOLYSACCHARIDE; PEPTIDE DERIVATIVE; PROTEIN; PROTEIN BLP 2; PROTEIN HLP 2; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTRICITY; ESCHERICHIA COLI; MEMBRANE; MINIMUM INHIBITORY CONCENTRATION; MODEL; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; CONSERVED SEQUENCE; ESCHERICHIA COLI; LACTOFERRIN; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

BOVINAE; ESCHERICHIA COLI;

EID: 4444302227     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsle.2004.07.038     Document Type: Article

References (17)

1. R.E. Hancock, and R. Lehrer Cationic peptides: a new source of antibiotics Trends Biotechnol. 16 1998 82 88
2. E. Martin, T. Ganz, and R.I. Lehrer Defensins and other endogenous peptide antibiotics of vertebrates J. Leukoc. Biol. 58 1995 128 136
3. H. Ulvatne, H.H. Haukland, O. Olsvik, and L.H. Vorland Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes FEBS Lett. 492 2001 62 65
4. W. Bellamy, M. Takase, K. Yamauchi, H. Wakabayashi, K. Kawase, and M. Tomita Identification of the bactericidal domain of lactoferrin Biochim. Biophys. Acta 1121 1992 130 136
5. S. Farnaud, and R.W. Evans Lactoferrin â€" a multifunctional protein with antimicrobial properties Mol. Immunol. 40 2003 395 405
6. E.N. Baker, B.F. Anderson, H.M. Baker, R.T. MacGillivray, S.A. Moore, N.A. Peterson, S.C. Shewry, and J.W. Tweedie Three-dimensional structure of lactoferrin. Implications for function, including comparisons with transferrin Adv. Exp. Med. Biol. 443 1998 1 14
7. E.N. Baker, H.M. Baker, and R.D. Kidd Lactoferrin and transferrin: functional variations on a common structural framework Biochem. Cell Biol. 80 2002 27 34
8. P.M. Hwang, N. Zhou, X. Shan, C.H. Arrowsmith, and H.J. Vogel Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin Biochemistry 37 1998 4288 4298
9. H. Mihara, and Y. Takahashi Engineering peptides and proteins that undergo alpha-to-beta transitions Curr. Opin. Struct. Biol. 7 1997 501 508
10. S. Farnaud, C. Spiller, L.C. Moriarty, A. Patel, V. Gant, E.W. Odell, and R.W. Evans Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity FEMS Microbiol. Lett. 233 2004 193 199
11. E.W. Odell, R. Sarra, M. Foxworthy, D.S. Chapple, and R.W. Evans Antibacterial activity of peptides homologous to a loop region in human lactoferrin FEBS Lett. 382 1996 175 178
12. D.S. Chapple, D.J. Mason, C.L. Joannou, E.W. Odell, V. Gant, and R.W. Evans Structureâ€"function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111 Infect. Immun. 66 1998 2434 2440
13. D.S. Chapple, R. Hussain, C.L. Joannou, R.E. Hancock, E. Odell, R.W. Evans, and G. Siligardi Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide Antimicrob. Agents Chemother. 48 2004 2190 2198
14. P.Y. Chou, and G.D. Fasman Prediction of the secondary structure of proteins from their amino acid sequence Adv. Enzymol. Relat. Areas Mol. Biol. 47 1978 45 148
15. E. Elass-Rochard, A. Roseanu, D. Legrand, M. Trif, V. Salmon, C. Motas, J. Montreuil, and G. Spik Lactoferrinâ€"lipopolysaccharide interaction: involvement of the 28â€"34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide Biochem. J. 312 Pt 3 1995 839 845
16. D. Caccavo, N.M. Pellegrino, M. Altamura, A. Rigon, L. Amati, A. Amoroso, and E. Jirillo Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application J. Endotoxin Res. 8 2002 403 417
17. X.L. Sun, H.M. Baker, S.C. Shewry, G.B. Jameson, and E.N. Baker Structure of recombinant human lactoferrin expressed in Aspergillus awamori Acta Crystallogr. D 55 Pt. 2 1999 403 407